Lundbeck tops Q3 expectations following strong sales of mental health drugs

Lundbeck tops Q3 expectations following strong sales of mental health drugs

Source: 
Pharmaforum
News Tags: 
snippet: 

Denmark’s Lundbeck has beat its expectations in third quarter results, following a strong performance from its portfolio of mental health drugs, although its newly-launched migraine drug seems to have got off to a slow start.